Skip to content

MK-777

Also called Acetamoren — MK-677 analog GHS

Described as a non-peptide agonist at the ghrelin receptor (GHS-R1a).

  • TypeSmall molecule
  • FormOral
  • Researched forGH & Growth

Where to get MK-777

Solution Peptides
Oral
Code CAMERON25

The only form sold. Research compound, not approved for human use.

Shop oral at Solution Peptides

The short version

  • Why people research itLean-mass support, recovery, sleep depth, connective-tissue repair and improved body composition via the GH/IGF-1 axis.
  • What the evidence isNone.
  • What to watchFast swelling of hands, feet or face.

How MK-777 works

Described as a non-peptide agonist at the ghrelin receptor (GHS-R1a) — the same receptor MK-677 acts on, and the same one the injectable ghrelin mimetics (Ipamorelin, GHRP-2/6) hit. Binding there triggers a GH pulse, which raises IGF-1 downstream. Orally bioavailable, which is the practical difference from the peptide secretagogues. Read that mechanism as a CLASS ASSIGNMENT rather than a measured finding: it follows from what the compound is sold as, and no published pharmacology confirms it.

The honest first sentence about MK-777 is that nobody outside the companies selling it knows what it is. A search of NCBI's PubTator3 index for MK-777 and for acetamoren returns zero records.

So this section describes the receptor it is claimed to act at, and labels that clearly as what it is. If MK-777 is what it is sold as, it is a non-peptide agonist at GHS-R1a, the growth hormone secretagogue receptor. That receptor is now understood at atomic resolution: Liu 2021 solved cryo-electron microscopy structures of the human ghrelin receptor bound to ghrelin and to the synthetic agonist ibutamoren — MK-677 — and described how each engages the binding pocket and how the receptor activates.

  • Oral

On the goal map: GH / IGF-1 axis (Build muscle & strength)

Research on MK-7777 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: None independent — no PubMed entry, no trial registry record, no published pharmacology. Every description traces to vendor copy.

Human clinical evidence

  • None. No PubMed entry, no clinical trial registry record, no published pharmacology. This is not a compound with thin human data — it is a compound with no independent data of any kind. Every description of it traces back to a vendor or a supplement retailer.

  • The '92% greater binding affinity than MK-677' figure has no source. It appears on several sales pages with no citation attached anywhere. It is named here so a reader who meets it knows it is untraceable, rather than assuming nobody checked.

Correlative data

  • MK-677 is the only real read available, and it is the honest comparator because MK-777 is sold explicitly as its successor. MK-677 reliably raises IGF-1, reliably raises appetite, and reliably causes fluid retention and a drift toward insulin resistance.

  • MK-677 also failed the outcome that mattered most: its hip-fracture trial in older adults did not deliver. Raising IGF-1 is not the same as producing a clinical result, and that is the most useful lesson the predecessor offers a compound with none of its own.

How the mechanism reads

  • Sold as a non-peptide agonist at the ghrelin receptor, GHS-R1a — the same receptor MK-677 and the injectable ghrelin mimetics act on. Oral bioavailability is the claimed practical advantage over the peptides.

    Mechanistic
  • The consequence people miss: this is a ghrelin mimetic. Running it beside MK-677, Ipamorelin, GHRP-2 or GHRP-6 is not a stack of two things. A GHRH analog (CJC-1295, Sermorelin) is the arm that genuinely pairs with it.

    Mechanistic
  • Treat the mechanism as a class assignment inherited from what it is sold as, not as a measured property of this molecule.

    Mechanistic

Sources

  • Liu H, et al. Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren. Nature Communications 2021 · PMID 34737341
  • Nass R, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Annals of Internal Medicine 2008 · PMID 18981485
  • Iwai N, et al. Gastrointestinal: Acute pancreatitis related to a ghrelin receptor agonist. Journal of Gastroenterology and Hepatology 2022 · PMID 35178754

MK-777 safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Pregnancy, or trying to conceive.
  • Cancer history: if it truly raises GH and IGF-1 it feeds growth signaling.
  • Diabetes or prediabetes: GH elevation lowers insulin sensitivity.
  • Under 18: GH-axis activation in growing bodies is unstudied for this compound.
  • Any wish for a known product: no independent record exists, so identity and purity are unverified.

What’s expected

  • If it acts as sold, hunger and water retention like other oral ghrelin receptor agonists.
  • Possibly no effect at all, since no independent pharmacology is published.
  • Any GH-like effect would raise IGF-1.

Watch for

  • Fast swelling of hands, feet or face.
  • Numbness in the fingers.
  • Rising thirst or urination.
  • Any rash, fever or reaction to the first uses.

Labs that tell you it’s working

  • IGF-1 (Insulin-like Growth Factor 1)
  • Insulin (Fasting)
  • HbA1c (Hemoglobin A1c)
  • Comprehensive Metabolic Panel (CMP)

Described only in vendor copy as an MK-677 analog; GHS-R1a is a class assignment, not a measurement.

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

MK-777 FAQ4 common questions

Is MK-777 approved for human use?
No. MK-777 is a research compound.
What is MK-777 researched for?
Lean-mass support, recovery, sleep depth, connective-tissue repair and improved body composition via the GH/IGF-1 axis.
Which labs show whether it's doing anything?
IGF-1; Insulin; HbA1c; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for MK-777: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what MK-777 is. Skool covers how it is run.

Free on this page

What MK-777 is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What MK-777 is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool